Improving decisions about the funding of high cost cancer medicines in Australia

改善澳大利亚高成本癌症药物的资助决策

• 批准号: nhmrc : 1080673
• 负责人: Dr Wendy Lipworth
• 金额: $ 37.96万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2015
• 资助国家: 澳大利亚
• 起止时间: 2015-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-decisions-funding-medicines-australia/518764
• 关键词: Improving; decisions; about; funding; cost

In this project, we will address the pressing policy question: How can those funding cancer medicines manage the intensifying economic and ethical challenges that they face? Specifically, we will explore ways of making funding decisions fairer and more legitimate in the eyes of different stakeholders, including patients, the general public, governments and pharmaceutical companies. We will also consider ways in which these guidelines might be generalised to the funding of other medicines.

在这个项目中，我们将解决紧迫的政策问题：那些资助癌症药物的人如何应对他们面临的日益加剧的经济和伦理挑战？具体而言，我们将探索如何使资金决策在不同利益相关者（包括患者，公众，政府和制药公司）眼中更公平，更合法。我们亦会考虑如何将这些指引推广至其他药物的资助。